⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNRX News
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
globenewswire.com
QNRX
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
globenewswire.com
QNRX
Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery
globenewswire.com
ILMN
DHR
BDX
BIO
BRKR
QGEN
XRAY
EXAS
TMO
ABT
AMGN
AGNC
AMZN
GOOG
QNRX
NVDA
IBM
MRNA
PFE
JNJ
BMY
GILD
AMAT
ASML
LRCX
KLAC
MU
AMD
INTC
SNOW
CRSP
EDIT
BEAM
REGN
VRTX
BIIB
LLY
ACN
MSFT
XOM
CVX
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
globenewswire.com
QNRX
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
globenewswire.com
QNRX
Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen
globenewswire.com
ABT
TMO
LH
RVTY
AGNC
BIO
ILMN
QNRX
MYGN
BIIB
ES
STRL
SSTK
CNMD
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
globenewswire.com
QNRX